Schroder Investment Management Group’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$66.6M Sell
892,354
-72,830
-8% -$5.43M 0.06% 235
2025
Q1
$61.3M Buy
965,184
+70,645
+8% +$4.49M 0.06% 244
2024
Q4
$69.8M Sell
894,539
-42,750
-5% -$3.34M 0.07% 233
2024
Q3
$75.3M Buy
937,289
+11,719
+1% +$942K 0.08% 215
2024
Q2
$76.6M Buy
925,570
+297,551
+47% +$24.6M 0.08% 200
2024
Q1
$53.6M Sell
628,019
-28,791
-4% -$2.46M 0.06% 274
2023
Q4
$56.2M Sell
656,810
-115,131
-15% -$9.84M 0.07% 250
2023
Q3
$69.2M Sell
771,941
-224,267
-23% -$20.1M 0.1% 193
2023
Q2
$84.8M Buy
996,208
+50,584
+5% +$4.31M 0.12% 167
2023
Q1
$78.3M Sell
945,624
-7,359
-0.8% -$609K 0.12% 178
2022
Q4
$75M Sell
952,983
-30,014
-3% -$2.36M 0.12% 178
2022
Q3
$72.8M Buy
982,997
+218,886
+29% +$16.2M 0.12% 169
2022
Q2
$49.8M Buy
764,111
+274,774
+56% +$17.9M 0.08% 257
2022
Q1
$30.9M Sell
489,337
-56,484
-10% -$3.57M 0.04% 390
2021
Q4
$29M Buy
545,821
+117,789
+28% +$6.25M 0.04% 394
2021
Q3
$30.2M Sell
428,032
-107,902
-20% -$7.62M 0.05% 388
2021
Q2
$35.7M Buy
535,934
+237,574
+80% +$15.8M 0.04% 378
2021
Q1
$33.1M Buy
298,360
+92,266
+45% +$10.2M 0.04% 394
2020
Q4
$24.5M Buy
+206,094
New +$24.5M 0.03% 432
2019
Q2
Sell
-9,465
Closed -$828K 1214
2019
Q1
$828K Sell
9,465
-170,690
-95% -$14.9M ﹤0.01% 940
2018
Q4
$18K Buy
180,155
+168,048
+1,388% +$16.8K 0.03% 459
2018
Q3
$1.39M Hold
12,107
﹤0.01% 862
2018
Q2
$1.08M Sell
12,107
-8,762
-42% -$783K ﹤0.01% 917
2018
Q1
$1.53M Hold
20,869
﹤0.01% 889
2017
Q4
$1.21M Sell
20,869
-15,325
-42% -$890K ﹤0.01% 953
2017
Q3
$1.57M Buy
+36,194
New +$1.57M ﹤0.01% 913
2014
Q2
Sell
-257,300
Closed -$8.39M 1407
2014
Q1
$8.39M Buy
257,300
+3,300
+1% +$108K 0.01% 670
2013
Q4
$10.7M Sell
254,000
-198,700
-44% -$8.37M 0.01% 629
2013
Q3
$18.1M Sell
452,700
-114,100
-20% -$4.55M 0.04% 469
2013
Q2
$23.4M Buy
+566,800
New +$23.4M 0.06% 375